D010654Chemicals & DrugsD02.241.223.651560.993028Phenylbutyratesprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAntonioBiancoAntonio Bianco41.7886000000000087.598699999999993717Bianco, AntonioProfessor1568297Shen WK, Tung RT, Kurachi YCirculation researchActivation of the cardiac ATP-sensitive K+ channel by ER-001533, a newly synthesized vasorelaxant. Circ Res. 1992 May; 70(5):1054-61.Circ Res1992-05-01T00:00:001992Activation of the cardiac ATP-sensitive K+ channel by ER-001533, a newly synthesized vasorelaxant.21237159da-Silva WS, Ribich S, Arrojo e Drigo R, Castillo M, Patti ME, Bianco ACFEBS lettersThe chemical chaperones tauroursodeoxycholic and 4-phenylbutyric acid accelerate thyroid hormone activation and energy expenditure. FEBS Lett. 2011 Feb 04; 585(3):539-44.FEBS Lett2011-01-14T00:00:002011The chemical chaperones tauroursodeoxycholic and 4-phenylbutyric acid accelerate thyroid hormone activation and energy expenditure.29913165Jara O, Minogue PJ, Berthoud VM, Beyer ECExperimental eye researchChemical chaperone treatment improves levels and distributions of connexins in Cx50D47A mouse lenses. Exp Eye Res. 2018 10; 175:192-198.Exp Eye Res2018-06-18T00:00:002018Chemical chaperone treatment improves levels and distributions of connexins in Cx50D47A mouse lenses.0.7236410.05827465research area of0.6700370.05868376subject area forPediatrics-Hematology and Oncology2108408Flowers BK, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RMOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck SurgeryThe effect of a leukotriene antagonist on the early response to antigen. Otolaryngol Head Neck Surg. 1990 Mar; 102(3):219-24.Otolaryngol Head Neck Surg1990-03-01T00:00:001990The effect of a leukotriene antagonist on the early response to antigen.http://www.BiancoLab.orgMy Lab Sitehttps://scholar.google.com/citations?user=d6I0YqIAAAAJ&hl=enMy Google Scholar siteMedicineUniversity of ChicagoMichaelBeckerMichael A. Becker41.78927490000000-87.601250000000001603Becker, MichaelEmeritus/Emerita, ProfessorRobertNaclerioRobert M. Naclerio41.78927490000000-87.601250000000001970Naclerio, RobertEmeritus/Emerita, ProfessorEric C.Beyer0mFrDrgQC8zMknJtY0fp/Cv/+94=Eric C. Beyer41.78927490000000-87.60125000000000459Beyer, Eric C.ProfessorViviana MBerthoud BarrandeguyViviana M Berthoud Barrandeguy41.78927490000000-87.60125000000000613Berthoud Barrandeguy, Viviana MResearch Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1ProfessorProfessortrue1Research ProfessorResearch Professortrue1ProfessorProfessortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professor24934933Guzman ML, Yang N, Sharma KK, Balys M, Corbett CA, Jordan CT, Becker MW, Steidl U, Abdel-Wahab O, Levine RL, Marcucci G, Roboz GJ, Hassane DCMolecular cancer therapeuticsSelective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia. Mol Cancer Ther. 2014 Aug; 13(8):1979-90.Mol Cancer Ther2014-06-16T00:00:002014Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia.Medicine-EndocrinologySurgery-Ohns